Ovarian cancers related to minimal access surgery

British Journal of Obstetrics and Gynaecology
R A CrawfordJ H Shepherd

Abstract

To review the clinical features of women with ovarian cancer on whom minimal access surgery has been performed and to determine guidelines for the safe use of minimal access surgery for adnexal masses. Postal survey of members of the British Gynaecological Cancer Society (BGCS) and retrospective case review. BGCS consultants used ultrasound scanning (70%) and serum CA-125 estimations (53%) prior to adnexal mass surgery. The membership felt that adnexal masses with solid elements, diameter greater than 8 cm, multi-ocular or bilateral cysts or increased blood flow on Doppler scanning should not be operated on by minimal access surgery. A positive family history was also considered to be a contraindication. A total of 29 cases of ovarian cancer were identified on whom MAS had been performed. The incidence of cases was 4.1% of referrals to a tertiary referral centre (the Royal Marsden Hospital). The median age of patients was 37 years (range 20 to 68 years) and 13 had State I cancers. The mean delay between diagnosis and staging was 6.5 weeks. Guidelines on the use of minimal access surgery in the management of adnexal masses need to be agreed. Women who have an ovarian cancer diagnosed whilst having minimal access surgery should h...Continue Reading

References

Sep 1, 1992·American Journal of Obstetrics and Gynecology·F NezhatB Benigno
Nov 1, 1992·Gynecologic Oncology·S M EisenkopH J Wang
Nov 1, 1992·Gynecologic Oncology·A R MayerP E Schwartz
Apr 1, 1991·Geburtshilfe und Frauenheilkunde·E Lehmann-WillenbrockK Semm
Jun 1, 1991·Geburtshilfe und Frauenheilkunde·F Dressler
Nov 1, 1990·American Journal of Obstetrics and Gynecology·W H Parker, J S Berek
Mar 1, 1990·Clinical Cardiology·A H KragelW C Roberts
Feb 1, 1988·The Australian & New Zealand Journal of Obstetrics & Gynaecology·P Brownridge
May 15, 1973·American Journal of Obstetrics and Gynecology·M J WebbT J Williams
Aug 1, 1994·British Journal of Cancer·E J JunorC R Gillis
Mar 1, 1994·British Journal of Obstetrics and Gynaecology·J H ShepherdD G Lowe
Oct 1, 1993·British Journal of Obstetrics and Gynaecology·A P DaviesD Oram
Jun 1, 1993·Clinical Obstetrics and Gynecology·V Seltzer
Jun 1, 1993·Clinical Obstetrics and Gynecology·W H Parker, J S Berek
Sep 1, 1994·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K. SjövallN. Einhorn

❮ Previous
Next ❯

Citations

Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·B. KobalL. Zaletel-Kragelj
Dec 3, 2003·Annals of the New York Academy of Sciences·Theodoros D Theodoridis, John N Bontis
Mar 20, 1999·Obstetrics and Gynecology Clinics of North America·D S Chi, J P Curtin
Apr 9, 2005·Surgical Oncology Clinics of North America·Robert Kim, Peter G Rose
Dec 1, 1996·American Journal of Obstetrics and Gynecology·J M ChildersE A Surwit
Dec 22, 1999·Gynecologic Oncology·A Leminen, P Lehtovirta
Sep 9, 1999·Journal of Surgical Oncology·G H EltabbakhT Paczos
Nov 1, 2001·Clinical Obstetrics and Gynecology·T P Manolitsas, J M Fowler
Oct 16, 1999·British Journal of Obstetrics and Gynaecology·R D ClaytonG Lane
May 1, 1996·British Journal of Obstetrics and Gynaecology·J H ShepherdG Kindermann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.